| Table 1: Patient Characteristics. |
| | Pt | Age | Sex | Site | Pathology | Indication of Treatment | DDD | TTLP | TTDP |
| | 1 | 53 | F | Chest | LMC | Adjuvant to surgery | 13 | | 61 | | 2 | 78 | F | Thigh | Pleomorphic | Adjuvant to surgery | 13 | | | | 3 | 65 | M | Groin | HGSTS | Palliation | 13 | | | | 4 | 71 | M | Pelvis | Myxoid Chondrosarcoma | Palliation | 13 | 266 | | | 5 | 86 | F | Calf | Chondrosarcoma | Palliation | 13 | | | | 6 | 68 | F | Pelvis | MFH | Palliation | 13 | | 413 | | 7 | 41 | M | Chest and thigh | SS | Palliation | 13 | 196 | 247 | | 8 | 59 | F | Thigh | Bone LMS | Palliation | 16 | | 56 | | 9 | 44 | M | Chest | HGSTS | Palliation | 13 | | 180 | | 10 | 49 | M | Thigh | MFH | Adjuvant to surgery | 15 | | 48 | | 11 | 51 | F | Foot | HGSTS | Palliation | 14 | | | | 12 | 50 | M | Pelvis | LMS | Palliation | 13 | | | | 13 | 60 | M | Groin | LMS | Adjuvant to surgery | 13 | | 90 | | 14 | 27 | M | Pelvis | Ewing | Palliation | 13 | | 5 | | 15 | 51 | F | Chest | LMS | Palliation | 13 | 12 | 12 | | 16 | 80 | F | Calf, groin, axilla | HGSTS | Palliation | 13 | | | | 17 | 95 | M | Thigh | LMS | Adjuvant to surgery | 13 | | 270 |
|
|
Key:Pt: Patient; F:Female; M: Male;LMS: Leiomyosarcoma; HGSTS: High Grade Soft Tissue Sarcoma; MFH: Malignant Fibro Hystiocytoma; SS: Synovial Sarcoma; DDD: Duration of dose delivery; TTLP: time to local progression; TTDM: time to distant progression (the latter 3 parameters all measured in days).
|